Quick Win by the Algorithm

Exact Sciences Corporation (EXAS)

On July 24^th, 2016, the I Know First algorithm gave a bullish signal of 31.7 for the ticker EXAS with a predictability indicator of 0.23. In accordance with the algorithm’s prediction, EXAS experienced a Quick Win by the Algorithm of a 54.25% increase in stock price in only 14 days.

Exact Sciences Corporation is a biotechnology firm focused on using molecular diagnostics to screen for cancer and identify candidates who may be at a higher risk of getting cancer.  The company was founded in 1995, and it has an approved and effective product for detecting colorectal cancer known as Cologuard. The product is an at-home stool DNA screening test which detects traits which indicate the presence of colorectal cancer or precancerous lesions.

I Know First has been following EXAS closely since mid-January when the algorithm accurately predicted that the stock would increase. The algorithm was right and EXAS increased of 54.25% from July 24^th to August 7^th.

In general, stool testing is an attractive means of testing for cancer because of its non-invasive nature.  The colorectal cancer screening industry stands to provide a growth platform for the company since colorectal cancer is the second deadliest cancer in the US. Demand, as well as sentiment for Cologuard, has been picking up, and the United States Preventive Services Task Force (USPSTF) has included the product as a recommended screening test for detecting colorectal cancer which could help push the demand for Cologuard. The product also had a high rating among patients who have used the product.